How M.D. was paid
$5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Markus Warmuth, M.D.Chief Executive Officer | $650,000 | $910,080 | $3,043,648 | $429,000 | $0 | $5,032,728 |
| Filip Janku, M.D., Ph.D.Chief Medical Officer | $520,000 | $255,960 | $852,221 | $299,600 | $14,000 | $1,941,781 |
| Phil Nickson, Ph.D.Chief Business and Legal Officer | $520,000 | $255,960 | $852,221 | $299,600 | $14,000 | $1,941,781 |
What changed and why
- $5MChief Executive Officer Markus Warmuth received total compensation of $5,032,728 in 2025, representing an increase from $2,440,811 in 2024.
- $650KBase salary for the Chief Executive Officer increased to $650,000 in 2025 from $616,400 in the prior year.
- $429KNon-equity incentive plan compensation for the Chief Executive Officer was $429,000 for 2025 performance.
- Stock and option awards for named executive officers were determined based on grant date fair values calculated under ASC Topic 718.
- Radford served as independent compensation consultant to the compensation committee to evaluate executive compensation elements.
- All named executive officers were eligible for annual cash bonuses based on company and individual performance metrics.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.